サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1367742

創傷ケアの世界市場：製品別、創傷別、エンドユーザー別、地域別-2028年までの予測

Wound Care Market by Product (Dressings, Devices, Biological Skin Substitutes, Sutures, Staplers), Wounds, End User, and Region - Global Forecast to 2028

出版日
ページ情報
英文 330 Pages
納期
即納可能 即納可能とは
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.02円
創傷ケアの世界市場：製品別、創傷別、エンドユーザー別、地域別-2028年までの予測
出版日: 2023年10月11日
発行: MarketsandMarkets
ページ情報: 英文 330 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

創傷ケアの市場規模は、予測期間中にCAGR 5.9％で拡大し、2023年の215億米ドルから2028年には286億米ドルに拡大すると予測されています。

この成長は、外傷の増加、外科的創傷の増加、外傷性創傷管理への支出の増加など、いくつかの要因によって推進されています。しかし、創傷ケア製品のバリデーションに関する課題や熟練した専門家の不足が、市場成長の大きな障害となっています。

調査範囲
対象範囲2021-2028年
基準年2022年
予測期間2023-2028年
単位米ドル
セグメント製品, 創傷, エンドユーザー, 地域
対象地域北米、欧州、アジア太平洋、ラテンアメリカ, 中東＆アフリカ

2022年には、高度創傷ケア製品分野が創傷ケア市場で最も高い成長率を占めました。この成長の主な要因は、外傷性創傷や外科的創傷の発生率の大幅な増加であり、このセグメントにおける高度創傷ケアソリューションの需要を大きく牽引しています。

2022年の創傷ケア市場では、慢性創傷分野が最も高い成長率を占めています。この成長の主な要因は高齢化です。世界的に高齢化人口が増加し、糖尿病、末梢動脈疾患、静脈疾患などの慢性疾患の有病率が高くなり、これらすべてが慢性創傷を引き起こす可能性があります。さまざまな地域でヘルスケア支出が増加し、ヘルスケアインフラが改善することで、専門的な創傷ケア製品へのアクセスが向上し、慢性創傷ケア市場の成長が促進されます。

2022年のCAGRは、在宅ケア分野が最も高くなりました。技術、遠隔医療、専門的な創傷ケア製品、熟練したヘルスケア専門家の在宅ケア環境への統合が、在宅での創傷ケア提供の進展を促進しています。

アジア太平洋が予測期間で最も大きなCAGRを達成すると予測されています。同地域では、外科的創傷を減らすことが重視され、外傷性創傷を効果的に管理することに重点が置かれていることが成長を後押ししています。

当レポートでは、世界の創傷ケア市場について調査し、製品別、創傷別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどをまとめています。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場概要

  • イントロダクション
  • 市場力学
  • 価格分析
  • 特許分析
  • バリューチェーン分析
  • サプライチェーン分析
  • エコシステム分析
  • ポーターのファイブフォース分析
  • 規制状況
  • PESTEL分析
  • 貿易分析
  • 技術分析
  • 2023年～2024年の主な会議とイベント
  • 顧客のビジネスに影響を与える動向/混乱
  • 主要な利害関係者と購入基準
  • ケーススタディ分析

第6章 創傷ケア市場、製品別

  • イントロダクション
  • 高度な創傷ケア製品
  • 外科用創傷ケア製品
  • 従来の創傷ケア製品

第7章 創傷ケア市場、創傷別

  • イントロダクション
  • 急性創傷
  • 慢性創傷

第8章 創傷ケア市場、エンドユーザー別

  • イントロダクション
  • 病院と診療所
  • 在宅医療
  • 長期介護施設
  • その他

第9章 創傷ケア市場、地域別

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第10章 競合情勢

  • 概要
  • 主要参入企業が採用した戦略
  • 主要参入企業の収益分析
  • 市場シェア分析
  • 企業評価マトリックス
  • スタートアップ/中小企業の評価マトリックス
  • 競合シナリオ

第11章 企業プロファイル

  • 主要参入企業
    • 3M COMPANY
    • CARDINAL HEALTH
    • MEDTRONIC PLC
    • SMITH & NEPHEW PLC
    • MOLNLYCKE HEALTH CARE AB
    • B. BRAUN MELSUNGEN AG
    • BAXTER INTERNATIONAL, INC.
    • CONVATEC GROUP PLC
    • PAUL HARTMANN AG
    • COLOPLAST A/S
    • ORGANOGENESIS INC.
    • MIMEDX GROUP, INC.
    • INTEGRA LIFESCIENCES CORPORATION
    • BIOVENTUS LLC
    • ZIMMER BIOMET HOLDINGS, INC.
  • その他の企業
    • ETHICON, INC.
    • DEROYAL INDUSTRIES, INC.
    • KERECIS
    • ACELL INC.
    • LOHMANN & RAUSCHER GMBH & CO. KG
    • MEDELA AG
    • TALLEY GROUP LTD.
    • WELCARE INDUSTRIES S.P.A
    • WUHAN VSD MEDICAL SCIENCE & TECHNOLOGY CO., LTD.
    • PENSAR MEDICAL, LLC
    • HAROMED BV
    • DERMARITE INDUSTRIES, LLC
    • MEDLINE INDUSTRIES, INC.
    • ADVANCIS MEDICAL LLC
    • MIL LABORATORIES PVT. LTD.

第12章 付録

目次
Product Code: MD 2611

The wound care market is anticipated to achieve a valuation of USD 28.6 billion by 2028, compared to its 2023 value of USD 21.5 billion, at a CAGR of 5.9% during the forecast period. This growth is propelled by several factors, including the rise in traumatic injuries, an increase in surgical wounds, and augmented spending on traumatic wound management. However, challenges related to wound care product validation and a shortage of skilled professionals pose as significant hurdles in the market's growth trajectory.

Scope of the Report
Years Considered for the Study2021-2028
Base Year2022
Forecast Period2023-2028
Units ConsideredValue (USD) billion
SegmentsProduct, wound type, end user and region
Regions coveredNorth America, Europe, Asia Pacific, Latin America, and the Middle East & Africa

"The advanced wound care products segment accounted for the highest growth rate in the wound care market, by product, during the forecast period."

The wound care market is segmented into advanced wound care products, traditional wound care products and surgical wound care products. In 2022, the advanced wound care products segment accounted for the highest growth rate in the wound care market. The growth can be primarily attributed to the substantial increase in the incidence of traumatic and surgical wounds, significantly driving the demand for advanced wound care solutions within this segment.

"The chronic wound segment accounted for the highest growth rate in the wound care market, by wound type, during the forecast period."

The wound care market is segmented into chronic wounds and acute wounds based on wound type. In 2022, the chronic wound segment has accounted for the highest growth rate in the wound care market. This growth can be primarily attributed to the aging population, with a global increase in the aging population, there is a higher prevalence of chronic diseases such as diabetes, peripheral artery disease, and venous diseases, all of which can lead to chronic wounds and Growing healthcare expenditure and improving healthcare infrastructure in various regions enable better access to specialized wound care products, thus promoting the growth of the chronic wound care market.

"Home care settings segment accounted for the highest CAGR."

Based on end users, the wound care market is segmented into hospitals and clinics, long-term patient care, home care settings and other end users. In 2022, the home care settings segment accounted for the highest CAGR. The integration of technology, telemedicine, specialized wound care products, and skilled healthcare professionals into home care settings is driving the advancement of wound care delivery at home.

"Asia Pacific: The fastest-growing region in wound care market."

The wound care market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa segments, foresees the Asia Pacific region achieving the most significant CAGR in the forecasted period. The growth is propelled by a heightened emphasis on reducing surgical wounds and an increased focus on effectively managing traumatic wounds within this region.

The primary interviews conducted for this report can be categorized as follows:

  • By Company Type: Tier 1 - 40%, Tier 2 - 30%, and Tier 3 - 30%
  • By Designation: C-level - 27%, D-level - 18%, and Others - 55%
  • By Region: North America - 51%, Europe - 21%, Asia Pacific - 18%, Latin America - 6% , and the Middle East & Africa - 4%

Lists of Companies Profiled in the Report:

  • 3M Company (US)
  • Smith & Nephew PLC (UK)
  • Cardinal Health (US)
  • Medtronic PLC (Ireland)
  • B. Braun Melsungen AG (Germany)
  • Baxter International, Inc. (US)
  • Molnlycke Health Care AB (Sweden)
  • Convatec Group (UK)
  • Paul Hartmann AG (Germany)
  • Coloplast A/S (Denmark)
  • Organogenesis Holdings Inc. (US)
  • MiMedx Group, Inc. (US)
  • Integra Life Sciences Holdings Corporation (US)
  • Bioventus (US)
  • Zimmer Biomet Holdings, Inc. (US)
  • Ethicon, Inc. (US)
  • DeRoyal Industries (US)
  • Kerecis (Iceland)
  • Acell (US)
  • Lohmann & Rauscher GmbH & Co. KG (Germany)
  • Medela Ag (Switzerland)
  • Talley Group (UK)
  • Welcare Industries SPA (Italy)
  • Wuhan VSD Medical Science & Technology Co. Ltd. (China)
  • Pensar Medical (US)
  • Haromed BVBA (Belgium)
  • DermaRite Industries LLC (US)
  • Medline Industries, Inc. (US)
  • Advancis Medical LLC (UK)
  • Mil Laboratories Pvt. Ltd. (India).

Research Coverage:

This research report categorizes the wound care market by products, wound type, end user and region. The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the wound care market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, key strategies; contracts, partnerships, agreements, new product launches, mergers and acquisitions, and recent developments associated with the wound care market. Competitive analysis of upcoming startups in the wound care market ecosystem is covered in this report.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall wound care market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, challenges, and opportunities.

The report provides insights on the following pointers:

  • Analysis of key Drivers (Rise in the prevalence of diseases and conditions that would impact wound healing capabilities, technological advancements in wound care products), Restraint ( High cost associated with advanced wound care products, risks associated with the use of advanced wound care products), Opportunities (Growth opportunities in emerging countries), Challenges (Growing instances of product recalls by regulatory bodies, dearth of awareness) influencing the growth of the wound care market.
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the wound care market.
  • Market Development: Comprehensive information about lucrative markets - the report analyses the wound care market across varied regions.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the wound care market.
  • Competitive Assessment: In-depth assessment of market ranking, growth strategies and product offerings of leading players like 3M Company (US), Smith & Nephew PLC (UK), Cardinal Health (US), and Medtronic PLC (Ireland), among others in the wound care market strategies.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS AND EXCLUSIONS OF STUDY
  • 1.3 MARKETS COVERED
    • 1.3.1 MARKET SEGMENTATION
    • 1.3.2 REGIONAL SCOPE
    • 1.3.3 YEARS CONSIDERED
  • 1.4 CURRENCY
  • 1.5 LIMITATIONS
  • 1.6 STAKEHOLDERS
  • 1.7 SUMMARY OF CHANGES
  • 1.8 RECESSION IMPACT

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
  • 2.2 RESEARCH APPROACH
    • FIGURE 1 WOUND CARE MARKET: RESEARCH DESIGN
    • 2.2.1 SECONDARY DATA
      • 2.2.1.1 Key data from secondary sources
    • 2.2.2 PRIMARY DATA
      • 2.2.2.1 Primary sources
      • 2.2.2.2 Key data from primary sources
      • 2.2.2.3 Key industry insights
      • 2.2.2.4 Breakdown of primary interviews
    • FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
    • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • 2.3 MARKET SIZE ESTIMATION
    • 2.3.1 BOTTOM-UP APPROACH
      • 2.3.1.1 Approach 1: Company revenue estimation approach
    • FIGURE 4 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH
      • 2.3.1.2 Approach 2: Presentations of companies and primary interviews
      • 2.3.1.3 Growth forecast
      • 2.3.1.4 CAGR projections
    • FIGURE 5 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
    • 2.3.2 TOP-DOWN APPROACH
    • FIGURE 6 WOUND CARE MARKET: TOP-DOWN APPROACH
  • 2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
    • FIGURE 7 DATA TRIANGULATION METHODOLOGY
  • 2.5 MARKET SHARE
  • 2.6 STUDY ASSUMPTIONS
  • 2.7 RISK ASSESSMENT
  • 2.8 METHODOLOGY & SCOPE-RELATED LIMITATIONS
  • 2.9 GROWTH RATE ASSUMPTIONS
  • 2.10 RECESSION IMPACT ON WOUND CARE MARKET

3 EXECUTIVE SUMMARY

    • FIGURE 8 WOUND CARE MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION)
    • FIGURE 9 WOUND CARE MARKET, BY WOUND TYPE, 2023 VS. 2028 (USD MILLION)
    • FIGURE 10 WOUND CARE MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
    • FIGURE 11 WOUND CARE MARKET, BY REGION, 2023 VS. 2028 (USD MILLION)

4 PREMIUM INSIGHTS

  • 4.1 WOUND CARE MARKET OVERVIEW
    • FIGURE 12 GROWING PREVALENCE OF DISEASES & HEALTH CONDITIONS THAT AFFECT WOUND HEALING CAPABILITIES TO DRIVE MARKET
  • 4.2 WOUND CARE MARKET SHARE, BY PRODUCT, 2023 VS. 2028
    • FIGURE 13 ADVANCED WOUND CARE PRODUCTS SEGMENT TO DOMINATE MARKET IN 2028
  • 4.3 WOUND CARE MARKET SHARE, BY WOUND TYPE, 2023 VS. 2028
    • FIGURE 14 CHRONIC WOUNDS SEGMENT DOMINATES MARKET DURING FORECAST PERIOD
  • 4.4 WOUND CARE MARKET SHARE, BY END USER, 2023 VS. 2028
    • FIGURE 15 HOSPITALS & CLINICS WILL CONTINUE TO DOMINATE MARKET IN 2028
  • 4.5 WOUND CARE MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • FIGURE 16 ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 17 WOUND CARE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Growing prevalence of diseases & health conditions that affect wound healing capabilities
        • 5.2.1.1.1 Growing geriatric population
        • 5.2.1.1.2 Rising prevalence of diabetes
    • FIGURE 18 PREVALENCE OF DIABETES IN ADULTS (20-79 YEARS), BY REGION, 2021 VS. 2045 (MILLION CASES)
    • TABLE 1 TOTAL HEALTH EXPENDITURE DUE TO DIABETES (20-79 YEARS), BY COUNTRY, 2021
        • 5.2.1.1.3 Increasing number of surgical procedures worldwide
      • 5.2.1.2 Rising expenditure on chronic wounds
      • 5.2.1.3 Increasing incidence of burn injuries
      • 5.2.1.4 Rising cases of traumatic injuries
    • TABLE 2 PREVALENCE OF ROAD ACCIDENTS
      • 5.2.1.5 Technological advancements in wound care products
      • 5.2.1.6 Rising use of regenerative medicine for wound management
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 High cost of advanced wound care products
    • TABLE 3 AVERAGE COST OF TREATMENT FOR DIABETIC FOOT ULCERS
      • 5.2.2.2 Risks associated with use of advanced wound care products
    • TABLE 4 RISKS ASSOCIATED WITH ADVANCED WOUND CARE PRODUCTS
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Growth potential of emerging countries
    • TABLE 5 STRATEGIC DEVELOPMENTS IN ASIA PACIFIC REGION
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Growing instances of product recalls by regulatory bodies
      • 5.2.4.2 Dearth of awareness
  • 5.3 PRICING ANALYSIS
    • TABLE 6 AVERAGE SELLING PRICE OF KEY PRODUCTS IN WOUND CARE MARKET (2022)
    • TABLE 7 AVERAGE SELLING PRICE TRENDS, BY REGION, 2022
  • 5.4 PATENT ANALYSIS
    • FIGURE 19 PATENT ANALYSIS OF WOUND CARE MARKET, JANUARY 2013-DECEMBER 2022
    • 5.4.1 LIST OF MAJOR PATENTS
  • 5.5 VALUE CHAIN ANALYSIS
    • FIGURE 20 VALUE CHAIN ANALYSIS OF WOUND CARE MARKET: MAJOR VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASES
  • 5.6 SUPPLY CHAIN ANALYSIS
    • FIGURE 21 WOUND CARE MARKET: SUPPLY CHAIN ANALYSIS
  • 5.7 ECOSYSTEM ANALYSIS
    • FIGURE 22 WOUND CARE MARKET: ECOSYSTEM ANALYSIS
    • 5.7.1 WOUND CARE MARKET: ROLE IN ECOSYSTEM
  • 5.8 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 8 WOUND CARE MARKET: PORTER'S FIVE FORCES ANALYSIS
    • 5.8.1 THREAT OF NEW ENTRANTS
    • 5.8.2 THREAT OF SUBSTITUTES
    • 5.8.3 BARGAINING POWER OF BUYERS
    • 5.8.4 BARGAINING POWER OF SUPPLIERS
    • 5.8.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.9 REGULATORY LANDSCAPE
    • TABLE 9 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 10 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 11 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 12 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 5.9.1 NORTH AMERICA
      • 5.9.1.1 US
      • 5.9.1.2 Canada
    • 5.9.2 EUROPE
    • 5.9.3 ASIA PACIFIC
      • 5.9.3.1 China
      • 5.9.3.2 Japan
      • 5.9.3.3 India
    • 5.9.4 LATIN AMERICA
      • 5.9.4.1 Brazil
      • 5.9.4.2 Mexico
    • 5.9.5 MIDDLE EAST
    • 5.9.6 AFRICA
  • 5.10 PESTEL ANALYSIS
  • 5.11 TRADE ANALYSIS
    • 5.11.1 TRADE ANALYSIS FOR ADHESIVE DRESSINGS
    • TABLE 13 IMPORT DATA FOR ADHESIVE DRESSINGS, BY COUNTRY, 2018-2022 (USD MILLION)
    • TABLE 14 EXPORT DATA FOR ADHESIVE DRESSINGS, BY COUNTRY, 2018-2022 (USD MILLION)
  • 5.12 TECHNOLOGY ANALYSIS
  • 5.13 KEY CONFERENCES & EVENTS IN 2023-2024
    • TABLE 15 WOUND CARE MARKET: DETAILED LIST OF CONFERENCES & EVENTS
  • 5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMER'S BUSINESS
    • 5.14.1 REVENUE SOURCES SHIFTING TOWARD TECHNOLOGY-BASED SOLUTIONS DUE TO COVID-19 PANDEMIC
    • 5.14.2 REVENUE SHIFT IN WOUND CARE MARKET
  • 5.15 KEY STAKEHOLDERS & BUYING CRITERIA
    • 5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • FIGURE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF WOUND CARE PRODUCTS
    • TABLE 16 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF WOUND CARE PRODUCTS (%)
    • 5.15.2 BUYING CRITERIA
    • FIGURE 24 KEY BUYING CRITERIA FOR WOUND CARE PRODUCTS
    • TABLE 17 KEY BUYING CRITERIA FOR WOUND CARE PRODUCTS
  • 5.16 CASE STUDY ANALYSIS
    • 5.16.1 CASE STUDY: SURGICAL WOUND TURNS AROUND IN 3 WEEKS

6 WOUND CARE MARKET, BY PRODUCT

  • 6.1 INTRODUCTION
    • TABLE 18 WOUND CARE MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • 6.1.1 PRIMARY NOTES
      • 6.1.1.1 Key industry insights
  • 6.2 ADVANCED WOUND CARE PRODUCTS
    • TABLE 19 ADVANCED WOUND CARE PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 20 ADVANCED WOUND CARE PRODUCTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.2.1 ADVANCED WOUND DRESSINGS, BY TYPE
    • TABLE 21 ADVANCED WOUND DRESSINGS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 22 ADVANCED WOUND DRESSINGS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
      • 6.2.1.1 Foam dressings
    • TABLE 23 KEY PRODUCTS IN FOAM DRESSINGS MARKET
    • TABLE 24 FOAM DRESSINGS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 25 FOAM DRESSINGS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • 6.2.1.1.1 Silicone dressings
          • 6.2.1.1.1.1 Help expedite wound closure and reduce risk of maceration
    • TABLE 26 SILICONE DRESSINGS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • 6.2.1.1.2 Non-silicone dressings
          • 6.2.1.1.2.1 Effective in scar removal and wound healing
    • TABLE 27 NON-SILICONE DRESSINGS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
      • 6.2.1.2 Hydrocolloid dressings
        • 6.2.1.2.1 Promotes moist environment required for optimal healing
    • TABLE 28 KEY PRODUCTS IN HYDROCOLLOID DRESSINGS MARKET
    • TABLE 29 HYDROCOLLOID DRESSINGS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
      • 6.2.1.3 Film dressings
        • 6.2.1.3.1 Non-absorbable nature ensures strong adoption
    • TABLE 30 FILM DRESSINGS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
      • 6.2.1.4 Alginate dressings
        • 6.2.1.4.1 Well-suited for diabetic & foot ulcers
    • TABLE 31 ALGINATE DRESSINGS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
      • 6.2.1.5 Hydrogel dressings
        • 6.2.1.5.1 Available in several forms for effective use
    • TABLE 32 HYDROGEL DRESSINGS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
      • 6.2.1.6 Collagen dressings
        • 6.2.1.6.1 Help release cytokines and growth factors that expedite wound healing
    • TABLE 33 COLLAGEN DRESSINGS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
      • 6.2.1.7 Hydrofiber dressings
        • 6.2.1.7.1 Combine properties of hydrocolloids and collagen
    • TABLE 34 HYDROFIBER DRESSINGS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
      • 6.2.1.8 Wound contact layers
        • 6.2.1.8.1 Protect wound beds from bacterial and fungal growth
    • TABLE 35 WOUND CONTACT LAYERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
      • 6.2.1.9 Superabsorbent dressings
        • 6.2.1.9.1 Designed for highly exuding wounds
    • TABLE 36 SUPERABSORBENT DRESSINGS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
      • 6.2.1.10 Other advanced wound dressings
    • TABLE 37 OTHER ADVANCED WOUND DRESSINGS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.2.2 ADVANCED WOUND DRESSINGS, BY PROPERTY
    • TABLE 38 ADVANCED WOUND DRESSINGS MARKET, BY PROPERTY, 2021-2028 (USD MILLION)
      • 6.2.2.1 Non-antimicrobial dressings
        • 6.2.2.1.1 More cost-effective than antimicrobial alternatives
    • TABLE 39 NON-ANTIMICROBIAL DRESSINGS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
      • 6.2.2.2 Antimicrobial dressings
        • 6.2.2.2.1 Provide comprehensive coverage against potential pathogens
    • TABLE 40 ANTIMICROBIAL DRESSINGS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.2.3 WOUND THERAPY DEVICES
    • TABLE 41 WOUND THERAPY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 42 WOUND THERAPY DEVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
      • 6.2.3.1 Portable & conventional negative pressure wound therapy devices
        • 6.2.3.1.1 Growing adoption of single-use NPWT devices in home care settings to drive market
    • TABLE 43 PORTABLE & CONVENTIONAL NPWT DEVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
      • 6.2.3.2 Debridement devices & accessories
        • 6.2.3.2.1 Development of novel technologies to support market growth
    • TABLE 44 DEBRIDEMENT DEVICES & ACCESSORIES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
      • 6.2.3.3 Wound assessment & monitoring devices
        • 6.2.3.3.1 Potential cost-reducing capabilities to boost adoption
    • TABLE 45 WOUND ASSESSMENT & MONITORING DEVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
      • 6.2.3.4 Other devices & accessories
    • TABLE 46 OTHER DEVICES & ACCESSORIES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.2.4 BIOLOGICAL SKIN SUBSTITUTES
    • TABLE 47 KEY PRODUCTS IN BIOLOGICAL SKIN SUBSTITUTES MARKET
    • TABLE 48 BIOLOGICAL SKIN SUBSTITUTES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 49 BIOLOGICAL SKIN SUBSTITUTES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
      • 6.2.4.1 Human donor tissue-derived products
        • 6.2.4.1.1 High efficacy to support market demand
    • TABLE 50 KEY PRODUCTS IN HUMAN DONOR TISSUE-DERIVED PRODUCTS MARKET
    • TABLE 51 HUMAN DONOR TISSUE-DERIVED PRODUCTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
      • 6.2.4.2 Acellular animal-derived products
        • 6.2.4.2.1 Increasing incidence of diabetic foot ulcers and burn injuries to drive market
    • TABLE 52 KEY PRODUCTS IN ACELLULAR ANIMAL-DERIVED PRODUCTS MARKET
    • TABLE 53 ACELLULAR ANIMAL-DERIVED PRODUCTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
      • 6.2.4.3 Biosynthetic products
        • 6.2.4.3.1 Increased incidence of infected wounds to support market growth
    • TABLE 54 BIOSYNTHETIC PRODUCTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.2.5 TOPICAL AGENTS
      • 6.2.5.1 Cost-effectiveness and ease-of-use in home care settings to drive growth
    • TABLE 55 TOPICAL AGENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • 6.3 SURGICAL WOUND CARE PRODUCTS
    • TABLE 56 SURGICAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 57 SURGICAL WOUND CARE PRODUCTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.3.1 SUTURES
      • 6.3.1.1 High tensile strength to drive adoption
    • TABLE 58 SUTURES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.3.2 TISSUE ADHESIVES, SEALANTS, AND GLUES
    • TABLE 59 TISSUE ADHESIVES, SEALANTS, AND GLUES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 60 TISSUE ADHESIVES, SEALANTS, AND GLUES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
      • 6.3.2.1 Fibrin-based sealants
        • 6.3.2.1.1 Provide better results than sutures
    • TABLE 61 FIBRIN-BASED SEALANTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
      • 6.3.2.2 Synthetic adhesives
        • 6.3.2.2.1 Additional sealing properties than traditional staples
    • TABLE 62 SYNTHETIC ADHESIVES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
      • 6.3.2.3 Collagen-based sealants
        • 6.3.2.3.1 Used in surgical procedures as adjuncts to hemostatic agents
    • TABLE 63 COLLAGEN-BASED SEALANTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.3.3 STAPLERS
      • 6.3.3.1 Faster and more accurate than suturing
    • TABLE 64 STAPLERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • 6.4 TRADITIONAL WOUND CARE PRODUCTS
    • TABLE 65 TRADITIONAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 66 TRADITIONAL WOUND CARE PRODUCTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.4.1 MEDICAL TAPES
      • 6.4.1.1 Used for primary wound treatment to cover and secure wounds
    • TABLE 67 MEDICAL TAPES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.4.2 DRESSINGS
      • 6.4.2.1 Presence of large patient population for pressure ulcers to drive market
    • TABLE 68 DRESSINGS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.4.3 CLEANSING AGENTS
      • 6.4.3.1 High risk of HAIs from open wounds to drive market
    • TABLE 69 TYPES OF CLEANSING AGENTS
    • TABLE 70 CLEANSING AGENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)

7 WOUND CARE MARKET, BY WOUND TYPE

  • 7.1 INTRODUCTION
    • TABLE 71 WOUND CARE MARKET, BY WOUND TYPE, 2021-2028 (USD MILLION)
  • 7.2 ACUTE WOUNDS
    • TABLE 72 WOUND CARE MARKET FOR ACUTE WOUNDS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 73 WOUND CARE MARKET FOR ACUTE WOUNDS, BY COUNTRY, 2021-2028 (USD MILLION)
    • 7.2.1 SURGICAL & TRAUMATIC WOUNDS
      • 7.2.1.1 Rising volume of surgical procedures to drive market
    • TABLE 74 WOUND CARE MARKET FOR SURGICAL & TRAUMATIC WOUNDS, BY COUNTRY, 2021-2028 (USD MILLION)
    • 7.2.2 BURNS
      • 7.2.2.1 High incidence of burn injuries to drive market
    • TABLE 75 WOUND CARE MARKET FOR BURNS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 7.3 CHRONIC WOUNDS
    • TABLE 76 WOUND CARE MARKET FOR CHRONIC WOUNDS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 77 WOUND CARE MARKET FOR CHRONIC WOUNDS, BY COUNTRY, 2021-2028 (USD MILLION)
    • 7.3.1 DIABETIC FOOT ULCERS
      • 7.3.1.1 Increasing prevalence of diabetes to support market growth
    • TABLE 78 TOTAL DIABETES-RELATED HEALTHCARE EXPENDITURE (20-79 AGE GROUP), 2021
    • TABLE 79 WOUND CARE MARKET FOR DIABETIC FOOT ULCERS, BY COUNTRY, 2021-2028 (USD MILLION)
    • 7.3.2 PRESSURE ULCERS
      • 7.3.2.1 Growing geriatric population to aid market growth
    • TABLE 80 WOUND CARE MARKET FOR PRESSURE ULCERS, BY COUNTRY, 2021-2028 (USD MILLION)
    • 7.3.3 VENOUS LEG ULCERS
      • 7.3.3.1 Rising prevalence of obesity to drive market
    • TABLE 81 WOUND CARE MARKET FOR VENOUS LEG ULCERS, BY COUNTRY, 2021-2028 (USD MILLION)
    • 7.3.4 OTHER CHRONIC WOUNDS
    • TABLE 82 COMMERCIALLY AVAILABLE WOUND CARE BIOLOGIC PRODUCTS FOR OTHER CHRONIC WOUNDS
    • TABLE 83 WOUND CARE MARKET FOR OTHER CHRONIC WOUNDS, BY COUNTRY, 2021-2028 (USD MILLION)

8 WOUND CARE MARKET, BY END USER

  • 8.1 INTRODUCTION
    • TABLE 84 WOUND CARE MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 8.2 HOSPITALS & CLINICS
    • TABLE 85 TOTAL NUMBER OF HOSPITALS, BY COUNTRY, 2021
    • TABLE 86 WOUND CARE MARKET FOR HOSPITALS & CLINICS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 87 WOUND CARE MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2021-2028 (USD MILLION)
    • 8.2.1 INPATIENT SETTINGS
      • 8.2.1.1 Increasing hospital admissions due to HAIs to drive market
    • TABLE 88 WOUND CARE MARKET FOR INPATIENT SETTINGS, BY COUNTRY, 2021-2028 (USD MILLION)
    • 8.2.2 OUTPATIENT SETTINGS
      • 8.2.2.1 Rising cost of inpatient facilities to increase demand for outpatient care settings
    • TABLE 89 WOUND CARE MARKET FOR OUTPATIENT SETTINGS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 8.3 HOME CARE SETTINGS
    • 8.3.1 LOW COST AND CONVENIENCE TO SUPPORT MARKET GROWTH
    • TABLE 90 WOUND CARE MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 8.4 LONG-TERM CARE FACILITIES
    • 8.4.1 GROWING GERIATRIC POPULATION TO INCREASE DEMAND FOR BETTER LONG-TERM CARE
    • TABLE 91 WOUND CARE MARKET FOR LONG-TERM CARE FACILITIES, BY COUNTRY, 2021-2028 (USD MILLION)
  • 8.5 OTHER END USERS
    • TABLE 92 WOUND CARE MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION)

9 WOUND CARE MARKET, BY REGION

  • 9.1 INTRODUCTIONS
    • TABLE 93 WOUND CARE MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 9.2 NORTH AMERICA
    • FIGURE 25 NORTH AMERICA: WOUND CARE MARKET SNAPSHOT
    • TABLE 94 NORTH AMERICA: WOUND CARE MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 95 NORTH AMERICA: WOUND CARE MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 96 NORTH AMERICA: ADVANCED WOUND CARE PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 97 NORTH AMERICA: ADVANCED WOUND DRESSINGS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 98 NORTH AMERICA: FOAM DRESSINGS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 99 NORTH AMERICA: ADVANCED WOUND DRESSINGS MARKET, BY PROPERTY, 2021-2028 (USD MILLION)
    • TABLE 100 NORTH AMERICA: WOUND THERAPY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 101 NORTH AMERICA: BIOLOGICAL SKIN SUBSTITUTES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 102 NORTH AMERICA: SURGICAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 103 NORTH AMERICA: TISSUE ADHESIVES, SEALANTS, AND GLUES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 104 NORTH AMERICA: TRADITIONAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 105 NORTH AMERICA: WOUND CARE MARKET, BY WOUND TYPE, 2021-2028 (USD MILLION)
    • TABLE 106 NORTH AMERICA: WOUND CARE MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.2.1 RECESSION IMPACT ON NORTH AMERICAN WOUND CARE MARKET
    • 9.2.2 US
      • 9.2.2.1 Rising incidence of chronic diseases and diabetes to drive market
    • TABLE 107 US: WOUND CARE MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 108 US: WOUND CARE MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.2.3 CANADA
      • 9.2.3.1 High prevalence of HAIs to support market growth
    • TABLE 109 CANADA: INCIDENCE OF DIABETES, 2022 VS. 2032
    • TABLE 110 CANADA: WOUND CARE MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 111 CANADA: WOUND CARE MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 9.3 EUROPE
    • TABLE 112 EUROPE: HEALTHCARE EXPENDITURE, BY COUNTRY (% OF GDP), 2022
    • TABLE 113 EUROPE: PREVALENCE OF DIABETES, 2021 VS. 2045
    • TABLE 114 EUROPE: WOUND CARE MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 115 EUROPE: WOUND CARE MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 116 EUROPE: ADVANCED WOUND CARE PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 117 EUROPE: ADVANCED WOUND DRESSINGS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 118 EUROPE: FOAM DRESSINGS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 119 EUROPE: ADVANCED WOUND DRESSINGS MARKET, BY PROPERTY, 2021-2028 (USD MILLION)
    • TABLE 120 EUROPE: WOUND THERAPY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 121 EUROPE: BIOLOGICAL SKIN SUBSTITUTES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 122 EUROPE: SURGICAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 123 EUROPE: TISSUE ADHESIVES, SEALANTS, AND GLUES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 124 EUROPE: TRADITIONAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 125 EUROPE: WOUND CARE MARKET, BY WOUND TYPE, 2021-2028 (USD MILLION)
    • TABLE 126 EUROPE: WOUND CARE MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.3.1 RECESSION IMPACT ON EUROPEAN WOUND CARE MARKET
    • 9.3.2 GERMANY
      • 9.3.2.1 Large diabetic population to support wound care product development and commercialization
    • TABLE 127 GERMANY: WOUND CARE MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 128 GERMANY: WOUND CARE MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.3.3 FRANCE
      • 9.3.3.1 Rising geriatric population to drive market growth
    • TABLE 129 FRANCE: WOUND CARE MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 130 FRANCE: WOUND CARE MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.3.4 UK
      • 9.3.4.1 Rising incidence of chronic wounds to propel market growth
    • TABLE 131 UK: WOUND CARE MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 132 UK: WOUND CARE MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.3.5 ITALY
      • 9.3.5.1 Improving quality and accessibility to medical care to support market growth
    • TABLE 133 ITALY: WOUND CARE MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 134 ITALY: WOUND CARE MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.3.6 SPAIN
      • 9.3.6.1 Increasing number of road traffic accidents to propel market
    • TABLE 135 SPAIN: WOUND CARE MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 136 SPAIN: WOUND CARE MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.3.7 RUSSIA
      • 9.3.7.1 Government focus on increasing diabetes awareness to favor market growth
    • TABLE 137 RUSSIA: WOUND CARE MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 138 RUSSIA: WOUND CARE MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.3.8 REST OF EUROPE
    • TABLE 139 REST OF EUROPE: WOUND CARE MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 140 REST OF EUROPE: ADVANCED WOUND CARE PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 141 REST OF EUROPE: ADVANCED WOUND DRESSINGS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 142 REST OF EUROPE: FOAM DRESSINGS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 143 REST OF EUROPE: ADVANCED WOUND DRESSINGS MARKET, BY PROPERTY, 2021-2028 (USD MILLION)
    • TABLE 144 REST OF EUROPE: WOUND THERAPY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 145 REST OF EUROPE: BIOLOGICAL SKIN SUBSTITUTES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 146 REST OF EUROPE: SURGICAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 147 REST OF EUROPE: TISSUE ADHESIVES, SEALANTS, AND GLUES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 148 REST OF EUROPE: TRADITIONAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 149 REST OF EUROPE: WOUND CARE MARKET, BY WOUND TYPE, 2021-2028 (USD MILLION)
    • TABLE 150 REST OF EUROPE: WOUND CARE MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 9.4 ASIA PACIFIC
    • FIGURE 26 ASIA PACIFIC: WOUND CARE MARKET SNAPSHOT
    • TABLE 151 ASIA PACIFIC: WOUND CARE MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 152 ASIA PACIFIC: WOUND CARE MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 153 ASIA PACIFIC: ADVANCED WOUND CARE PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 154 ASIA PACIFIC: ADVANCED WOUND DRESSINGS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 155 ASIA PACIFIC: FOAM DRESSINGS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 156 ASIA PACIFIC: ADVANCED WOUND DRESSINGS MARKET, BY PROPERTY, 2021-2028 (USD MILLION)
    • TABLE 157 ASIA PACIFIC: WOUND THERAPY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 158 ASIA PACIFIC: BIOLOGICAL SKIN SUBSTITUTES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 159 ASIA PACIFIC: SURGICAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 160 ASIA PACIFIC: TISSUE ADHESIVES, SEALANTS, AND GLUES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 161 ASIA PACIFIC: TRADITIONAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 162 ASIA PACIFIC: WOUND CARE MARKET, BY WOUND TYPE, 2021-2028 (USD MILLION)
    • TABLE 163 ASIA PACIFIC: WOUND CARE MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.4.1 RECESSION IMPACT ON ASIA PACIFIC WOUND CARE MARKET
    • 9.4.2 CHINA
      • 9.4.2.1 Increasing incidence of diabetic foot ulcers to drive market
    • TABLE 164 CHINA: WOUND CARE MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 165 CHINA: WOUND CARE MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.4.3 JAPAN
      • 9.4.3.1 Presence of well-developed healthcare system to favor market growth
    • TABLE 166 JAPAN: WOUND CARE MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 167 JAPAN: WOUND CARE MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.4.4 INDIA
      • 9.4.4.1 Growing medical tourism to support market growth
    • TABLE 168 INDIA: WOUND CARE MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 169 INDIA: WOUND CARE MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.4.5 AUSTRALIA
      • 9.4.5.1 Increasing initiatives to spread awareness of effective wound care to propel market
    • TABLE 170 AUSTRALIA: WOUND CARE MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 171 AUSTRALIA: WOUND CARE MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.4.6 SOUTH KOREA
      • 9.4.6.1 Rising geriatric population to aid market growth
    • TABLE 172 SOUTH KOREA: WOUND CARE MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 173 SOUTH KOREA: WOUND CARE MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.4.7 SINGAPORE
      • 9.4.7.1 Growing prevalence of diabetes to support market growth
    • TABLE 174 SINGAPORE: WOUND CARE MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 175 SINGAPORE: WOUND CARE MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.4.8 REST OF ASIA PACIFIC
    • TABLE 176 REST OF ASIA PACIFIC: WOUND CARE MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 177 REST OF ASIA PACIFIC: ADVANCED WOUND CARE PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 178 REST OF ASIA PACIFIC: ADVANCED WOUND DRESSINGS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 179 REST OF ASIA PACIFIC: FOAM DRESSINGS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 180 REST OF ASIA PACIFIC: ADVANCED WOUND DRESSINGS MARKET, BY PROPERTY, 2021-2028 (USD MILLION)
    • TABLE 181 REST OF ASIA PACIFIC: WOUND THERAPY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 182 REST OF ASIA PACIFIC: BIOLOGICAL SKIN SUBSTITUTES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 183 REST OF ASIA PACIFIC: SURGICAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 184 REST OF ASIA PACIFIC: TISSUE ADHESIVES, SEALANTS, AND GLUES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 185 REST OF ASIA PACIFIC: TRADITIONAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 186 REST OF ASIA PACIFIC: WOUND CARE MARKET, BY WOUND TYPE, 2021-2028 (USD MILLION)
    • TABLE 187 REST OF ASIA PACIFIC: WOUND CARE MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 9.5 LATIN AMERICA
    • TABLE 188 LATIN AMERICA: WOUND CARE MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 189 LATIN AMERICA: WOUND CARE MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 190 LATIN AMERICA: ADVANCED WOUND CARE PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 191 LATIN AMERICA: ADVANCED WOUND DRESSINGS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 192 LATIN AMERICA: FOAM DRESSINGS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 193 LATIN AMERICA: ADVANCED WOUND DRESSINGS MARKET, BY PROPERTY, 2021-2028 (USD MILLION)
    • TABLE 194 LATIN AMERICA: WOUND THERAPY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 195 LATIN AMERICA: BIOLOGICAL SKIN SUBSTITUTES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 196 LATIN AMERICA: SURGICAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 197 LATIN AMERICA: TISSUE ADHESIVES, SEALANTS, AND GLUES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 198 LATIN AMERICA: TRADITIONAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 199 LATIN AMERICA: WOUND CARE MARKET, BY WOUND TYPE, 2021-2028 (USD MILLION)
    • TABLE 200 LATIN AMERICA: WOUND CARE MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.5.1 RECESSION IMPACT ON LATIN AMERICAN WOUND CARE MARKET
    • 9.5.2 BRAZIL
      • 9.5.2.1 Largest healthcare market in Latin America
    • TABLE 201 BRAZIL: WOUND CARE MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 202 BRAZIL: WOUND CARE MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.5.3 MEXICO
      • 9.5.3.1 Increasing burden of diabetes to propel market
    • TABLE 203 MEXICO: WOUND CARE MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 204 MEXICO: WOUND CARE MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.5.4 REST OF LATIN AMERICA
    • TABLE 205 REST OF LATIN AMERICA: WOUND CARE MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 206 REST OF LATIN AMERICA: ADVANCED WOUND CARE PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 207 REST OF LATIN AMERICA: ADVANCED WOUND DRESSINGS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 208 REST OF LATIN AMERICA: FOAM DRESSINGS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 209 REST OF LATIN AMERICA: ADVANCED WOUND DRESSINGS MARKET, BY PROPERTY, 2021-2028 (USD MILLION)
    • TABLE 210 REST OF LATIN AMERICA: WOUND THERAPY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 211 REST OF LATIN AMERICA: BIOLOGICAL SKIN SUBSTITUTES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 212 REST OF LATIN AMERICA: SURGICAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 213 REST OF LATIN AMERICA: TISSUE ADHESIVES, SEALANTS, AND GLUES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 214 REST OF LATIN AMERICA: TRADITIONAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 215 REST OF LATIN AMERICA: WOUND CARE MARKET, BY WOUND TYPE, 2021-2028 (USD MILLION)
    • TABLE 216 REST OF LATIN AMERICA: WOUND CARE MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 9.6 MIDDLE EAST & AFRICA
    • 9.6.1 RISING PREVALENCE OF DIABETES TO SUPPORT MARKET GROWTH
    • TABLE 217 MIDDLE EAST & AFRICA: WOUND CARE MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 218 MIDDLE EAST & AFRICA: ADVANCED WOUND CARE PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 219 MIDDLE EAST & AFRICA: ADVANCED WOUND DRESSINGS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 220 MIDDLE EAST & AFRICA: FOAM DRESSINGS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 221 MIDDLE EAST & AFRICA: ADVANCED WOUND DRESSINGS MARKET, BY PROPERTY, 2021-2028 (USD MILLION)
    • TABLE 222 MIDDLE EAST & AFRICA: WOUND THERAPY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 223 MIDDLE EAST & AFRICA: BIOLOGICAL SKIN SUBSTITUTES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 224 MIDDLE EAST & AFRICA: SURGICAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 225 MIDDLE EAST & AFRICA: TISSUE ADHESIVES, SEALANTS, AND GLUES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 226 MIDDLE EAST & AFRICA: TRADITIONAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 227 MIDDLE EAST & AFRICA: WOUND CARE MARKET, BY WOUND TYPE, 2021-2028 (USD MILLION)
    • TABLE 228 MIDDLE EAST & AFRICA: WOUND CARE MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.6.2 RECESSION IMPACT ON MIDDLE EAST & AFRICAN WOUND CARE MARKET

10 COMPETITIVE LANDSCAPE

  • 10.1 OVERVIEW
  • 10.2 STRATEGIES ADOPTED BY KEY PLAYERS
    • 10.2.1 OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS IN WOUND CARE MARKET
    • TABLE 229 OVERVIEW OF STRATEGIES ADOPTED BY KEY WOUND CARE COMPANIES
  • 10.3 REVENUE ANALYSIS OF TOP MARKET PLAYERS
    • FIGURE 27 REVENUE ANALYSIS OF TOP PLAYERS IN WOUND CARE MARKET, 2018-2022 (USD MILLION)
  • 10.4 MARKET SHARE ANALYSIS
    • 10.4.1 WOUND CARE MARKET
    • FIGURE 28 WOUND CARE MARKET SHARE ANALYSIS, BY KEY PLAYER, 2022
    • TABLE 230 WOUND CARE MARKET: DEGREE OF COMPETITION
    • 10.4.2 ADVANCED WOUND CARE MARKET
    • FIGURE 29 ADVANCED WOUND CARE MARKET SHARE ANALYSIS, BY KEY PLAYER, 2022
    • 10.4.3 NEGATIVE PRESSURE WOUND THERAPY (NPWT) MARKET
    • FIGURE 30 NEGATIVE PRESSURE WOUND THERAPY MARKET SHARE ANALYSIS, BY KEY PLAYER, 2022
    • 10.4.4 ADVANCED WOUND DRESSINGS MARKET
    • FIGURE 31 ADVANCED WOUND DRESSINGS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2022
    • 10.4.5 SURGICAL SUTURES MARKET
    • FIGURE 32 SURGICAL SUTURES MARKET SHARE ANALYSIS, BY KEY PLAYER, 2022
    • 10.4.6 DEBRIDEMENT DEVICES MARKET
    • FIGURE 33 DEBRIDEMENT DEVICES MARKET SHARE ANALYSIS, BY KEY PLAYER, 2022
    • 10.4.7 TRADITIONAL AND SURGICAL WOUND CARE PRODUCTS MARKET
    • TABLE 231 TRADITIONAL AND SURGICAL WOUND CARE PRODUCTS MARKET RANKING ANALYSIS, BY KEY PLAYER, 2022
  • 10.5 COMPANY EVALUATION MATRIX
    • 10.5.1 LIST OF EVALUATED VENDORS
    • 10.5.2 STARS
    • 10.5.3 EMERGING LEADERS
    • 10.5.4 PERVASIVE PLAYERS
    • 10.5.5 PARTICIPANTS
    • FIGURE 34 WOUND CARE MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS, 2022
    • 10.5.6 COMPANY FOOTPRINT
    • FIGURE 35 PRODUCT AND REGIONAL FOOTPRINT ANALYSIS OF TOP PLAYERS IN WOUND CARE MARKET
    • TABLE 232 PRODUCT FOOTPRINT ANALYSIS OF TOP PLAYERS IN WOUND CARE MARKET
    • TABLE 233 REGIONAL FOOTPRINT ANALYSIS OF TOP PLAYERS IN WOUND CARE MARKET
  • 10.6 STARTUP/SME EVALUATION MATRIX
    • 10.6.1 PROGRESSIVE COMPANIES
    • 10.6.2 RESPONSIVE COMPANIES
    • 10.6.3 DYNAMIC COMPANIES
    • 10.6.4 STARTING BLOCKS
    • FIGURE 36 WOUND CARE MARKET: COMPANY EVALUATION MATRIX FOR STARTUPS/SMES, 2022
    • 10.6.5 COMPETITIVE BENCHMARKING
    • TABLE 234 WOUND CARE MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS
    • TABLE 235 WOUND CARE MARKET: DETAILED LIST OF KEY STARTUPS/SMES
  • 10.7 COMPETITIVE SCENARIO
    • 10.7.1 PRODUCT LAUNCHES
    • TABLE 236 KEY PRODUCT LAUNCHES
    • 10.7.2 DEALS
    • TABLE 237 KEY DEALS

11 COMPANY PROFILES

  • 11.1 KEY PLAYERS
  • (Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))**
    • 11.1.1 3M COMPANY
    • TABLE 238 3M COMPANY: COMPANY OVERVIEW
    • FIGURE 37 3M COMPANY: COMPANY SNAPSHOT (2022)
    • 11.1.2 CARDINAL HEALTH
    • TABLE 239 CARDINAL HEALTH: COMPANY OVERVIEW
    • FIGURE 38 CARDINAL HEALTH: COMPANY SNAPSHOT (2022)
    • 11.1.3 MEDTRONIC PLC
    • TABLE 240 MEDTRONIC PLC: COMPANY OVERVIEW
    • FIGURE 39 MEDTRONIC PLC: COMPANY SNAPSHOT (2022)
    • 11.1.4 SMITH & NEPHEW PLC
    • TABLE 241 SMITH & NEPHEW PLC: COMPANY OVERVIEW
    • FIGURE 40 SMITH & NEPHEW PLC: COMPANY SNAPSHOT (2022)
    • 11.1.5 MOLNLYCKE HEALTH CARE AB
    • TABLE 242 MOLNLYCKE HEALTH CARE AB: COMPANY OVERVIEW
    • FIGURE 41 MOLNLYCKE HEALTH CARE AB: COMPANY SNAPSHOT (2022)
    • 11.1.6 B. BRAUN MELSUNGEN AG
    • TABLE 243 B. BRAUN MELSUNGEN AG: COMPANY OVERVIEW
    • FIGURE 42 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2022)
    • 11.1.7 BAXTER INTERNATIONAL, INC.
    • TABLE 244 BAXTER INTERNATIONAL, INC.: COMPANY OVERVIEW
    • FIGURE 43 BAXTER INTERNATIONAL, INC.: COMPANY SNAPSHOT (2022)
    • 11.1.8 CONVATEC GROUP PLC
    • TABLE 245 CONVATEC GROUP PLC: COMPANY OVERVIEW
    • FIGURE 44 CONVATEC GROUP: COMPANY SNAPSHOT (2022)
    • 11.1.9 PAUL HARTMANN AG
    • TABLE 246 PAUL HARTMANN AG: COMPANY OVERVIEW
    • FIGURE 45 PAUL HARTMANN AG: COMPANY SNAPSHOT (2022)
    • 11.1.10 COLOPLAST A/S
    • TABLE 247 COLOPLAST A/S: COMPANY OVERVIEW
    • FIGURE 46 COLOPLAST A/S: COMPANY SNAPSHOT (2022)
    • 11.1.11 ORGANOGENESIS INC.
    • TABLE 248 ORGANOGENESIS INC.: COMPANY OVERVIEW
    • FIGURE 47 ORGANOGENESIS INC.: COMPANY SNAPSHOT (2022)
    • 11.1.12 MIMEDX GROUP, INC.
    • TABLE 249 MIMEDX GROUP, INC.: COMPANY OVERVIEW
    • FIGURE 48 MIMEDX GROUP, INC.: COMPANY SNAPSHOT (2022)
    • 11.1.13 INTEGRA LIFESCIENCES CORPORATION
    • TABLE 250 INTEGRA LIFESCIENCES CORPORATION: COMPANY OVERVIEW
    • FIGURE 49 INTEGRA LIFESCIENCES CORPORATION: COMPANY SNAPSHOT (2022)
    • 11.1.14 BIOVENTUS LLC
    • TABLE 251 BIOVENTUS LLC: COMPANY OVERVIEW
    • FIGURE 50 BIOVENTUS LLC: COMPANY SNAPSHOT (2022)
    • 11.1.15 ZIMMER BIOMET HOLDINGS, INC.
    • TABLE 252 ZIMMER BIOMET HOLDINGS, INC.: COMPANY OVERVIEW
    • FIGURE 51 ZIMMER BIOMET HOLDINGS, INC.: COMPANY SNAPSHOT (2022)
  • 11.2 OTHER PLAYERS
    • 11.2.1 ETHICON, INC.
    • TABLE 253 ETHICON, INC.: COMPANY OVERVIEW
    • 11.2.2 DEROYAL INDUSTRIES, INC.
    • TABLE 254 DEROYAL INDUSTRIES, INC.: COMPANY OVERVIEW
    • 11.2.3 KERECIS
    • TABLE 255 KERECIS: COMPANY OVERVIEW
    • 11.2.4 ACELL INC.
    • TABLE 256 ACELL INC.: COMPANY OVERVIEW
    • 11.2.5 LOHMANN & RAUSCHER GMBH & CO. KG
    • TABLE 257 LOHMANN & RAUSCHER GMBH & CO. KG: COMPANY OVERVIEW
    • 11.2.6 MEDELA AG
    • TABLE 258 MEDELA AG: COMPANY OVERVIEW
    • 11.2.7 TALLEY GROUP LTD.
    • TABLE 259 TALLEY GROUP LTD.: COMPANY OVERVIEW
    • 11.2.8 WELCARE INDUSTRIES S.P.A
    • TABLE 260 WELCARE INDUSTRIES S.P.A: COMPANY OVERVIEW
    • 11.2.9 WUHAN VSD MEDICAL SCIENCE & TECHNOLOGY CO., LTD.
    • TABLE 261 WUHAN VSD MEDICAL SCIENCE & TECHNOLOGY CO., LTD.: COMPANY OVERVIEW
    • 11.2.10 PENSAR MEDICAL, LLC
    • TABLE 262 PENSAR MEDICAL, LLC: COMPANY OVERVIEW
    • 11.2.11 HAROMED BV
    • TABLE 263 HAROMED BV: COMPANY OVERVIEW
    • 11.2.12 DERMARITE INDUSTRIES, LLC
    • TABLE 264 DERMARITE INDUSTRIES, LLC: COMPANY OVERVIEW
    • 11.2.13 MEDLINE INDUSTRIES, INC.
    • TABLE 265 MEDLINE INDUSTRIES, INC.: COMPANY OVERVIEW
    • 11.2.14 ADVANCIS MEDICAL LLC
    • TABLE 266 ADVANCIS MEDICAL LLC: COMPANY OVERVIEW
    • 11.2.15 MIL LABORATORIES PVT. LTD.
    • TABLE 267 MIL LABORATORIES PVT. LTD.: COMPANY OVERVIEW
  • *Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

12 APPENDIX

  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.3 CUSTOMIZATION OPTIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS